VA111913 Dysmenorrhoea Efficacy and Safety Proof of Concept
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Bell
Bio-Kinetic Europe Limited
Principal Investigator - Louise Taber
Pivotal Research Centers
Principal Investigator - Stephen E Daniels
Premier Research
Principal Investigator - Vernon Yamashiro
Jean Brown Research
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Bio-Kinetic Europe Limited
Belfast, United Kingdom
- Pivotal Research Centers
Peoria, Arizona, United States
- Premier Research Group
Austin, Texas, United States
- Jean Brown Research
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2009
- Primary completion
- 30 Sept 2010
- Completion
- 30 Nov 2010
- Last update posted
- 22 May 2014
- Registered enrollment
- 146
- Registry id
- NCT00963053
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.